-
Deaths from unexplained kidney disease rose to 178 in Indonesia
Time of Update: 2022-11-15
(End) Indonesian Health Minister Budi Gunadi Sadikin reported in Jakarta on the 2nd that the number of cases of unexplained kidney disease reported in the country has increased to 325, of which 178 deaths.
-
Micro Classroom No. 13 Professor Warburglar: Clinical management of daratumumab
Time of Update: 2022-10-21
Common methods and advantages and disadvantages of eliminating Dara blood transfusion interference5For patients treated with Vara with potential transfusion needs, the clinical management process recommended by expert consensus above should be referred to (Figure 4).
-
Express Screens Suitable Lung Cancer Patients for Blockbuster ADC Therapy, Liquid Biopsy Approved by FDA
Time of Update: 2022-08-20
▲If you have any business needs, please long press to scan the QR code above, or▎Edited by WuXi AppTec Content TeamImage source: Guardant Health official websiteWuXi AppTec provides integrated, end-to-end new drug R&D and production services for the global biopharmaceutical industry, covering chemical drug R&D and production, biological research, preclinical testing and clinical trial R&D, cell and gene therapy R&D, testing and production and other fields .
-
Blood: Scientists identify novel genetic target to treat adult blood cancer
Time of Update: 2022-05-18
org/blood/article-abstract/139/10/1541/482776/Genome-wide-CRISPR-screen-identifies-CDK6-as-a?redirectedFrom=fulltext"Our findings suggest that CDK6 may be a very attractive target for the treatment of ATLL, and that in some ATLL cell lines, loss of TP53 function may render cells resistant to the CDK6 inhibitor Palbociclib," said researcher Nakagawa.
-
New regulations for continuing education of licensed pharmacists are here
Time of Update: 2021-08-29
In accordance with the requirements of the "Draft of Opinions", the pharmacy professional and technical personnel who participate in continuing education through the following methods will be included in the continuing education hours of the year:1.
-
Eisai is pinched first / Chia Tai Tianqing Lunvatinib is approved
Time of Update: 2021-08-05
Two negotiations for lenvatinib to cut the price of 80% to enter the medical insurance After lenvatinib is on the market, the domestic price is 16,800 yuan/box, the specification is 4mg, 30 capsules .
The medical insurance payment price of Bayer Sorafenib is 5700 yuan/box (0.
-
Biotech: Adalimumab injection obtained approval for drug supplement application
Time of Update: 2021-04-27
On the 24th, Biotech announced that the company has recently received a "Drug Supplementary Application for Adalimumab Injection (trade name: Glerli®) approved and issued by the National Medical Products Administration ("National Medical Products Administration").
The drug has been approved for new indications and new specifications: polyarticular juvenile idiopathic arthritis (40mg/0.
-
Drug Administration: Catalog of Generic Drug Ginseng Preparations (39th Batch
Time of Update: 2021-03-23
35 34，，（）。 。 ：（） 76%; height: 30px"> 42%; height: 30px"> 06%; height: 30px"> / 96%; height: 30px"> 3%; height: 30px"> 4%; height: 30px"> 1 06%; height: 30px"> 2 76%; height: 30px"
-
Synthesis of AApeptides
Time of Update: 2021-03-02
A wide range of new peptide mimics with novel structures and functions are urgently needed to be exploredin order to identify potential drug candidates and targeted probes, and to study protein functions.
AApeptides are a new classof peptide mimics based on chiral PNA backbone.
-
Liao let go of the Chinese medicine formula particles in the national blank area is not much left
Time of Update: 2021-02-28
On June 19th, Liaoning Provincial Health and Planning Commission, Industry and Information Technology Commission and Food and Drug Administration jointly issued the Notice on the Declaration of Special Projects for Research on Chinese Medicine Formula Particles in Liaoning Province (hereinafter referred to as Notification).
-
More than $200 million in partnership with Pfizer/Dewpoint to develop potential DM1 therapies
Time of Update: 2021-01-23
On January 6, Dewpoint announced a new research collaboration with Pfizer to develop a potential treatment for severe muscular dystrophy Type 1 (DM1).
biotechnology companies in the United States and Germany are working on condensed matter, a new area of research that could help explain some aspects of cell biology that remain mysterious to researchers.
-
Microcore creatures
Time of Update: 2021-01-04
("Microcore Biotech") in the study of anti-tumor original innovative drug Chiauranib capsule by the State Drug Administration Drug Review Center (CDE) officially included in the "breakthrough treatment drug varieties", into the adaptation of the market approval as the target of confirmed Phase III clinical trials for the treatment of patients with progression or recurrence of small cell lung cancer (SCLC) after a 2-line system chemotherapy program.
-
AGCO Biogenes antiviral class 1 new drug is planned to be included in breakthrough treatment products
Time of Update: 2020-10-03
Aico Baifa announced that Ziresovir, a new drug against respiratory syncytial virus, has completed an international Phase II clinical proof-of-concept trial for the treatment of hospitalized infants and young children and achieved breakthrough results.
-
Domestic anti-cancer new drugs approved for listing increased by 125% YoY, forcing MNC, Hengrui, Baiji hit out head
Time of Update: 2020-10-02
Among them, the local new sharp represented by Baiji Shenzhou with the approval of two new drugs, and Heng Rui Qiping, and Hengrui with the expansion of 2 PD-1 new adaptive disorders, directly forced the K medicine of Merca East, in this innovation battle, the local pharmaceutical companies are ferociously surrounding MNC.
-
Does the NCBI support lianhua Qing plague cure the new crown - God-making or disinformation
Time of Update: 2020-09-27
Introduction: The National Biotechnology Information Center of the United States issued a paper, even flower plague treatment of the new crown effect is significant?!
In recent days, there have been intermittent "positive energy" users to publicize: the National Biotechnology Information Center has issued a message, even flower plague treatment of the new crown effect is remarkable!
